Open Access Open Access  Restricted Access Subscription or Fee Access

Biobetter Formulations: Innovative Milestone for Original Biologics

Pandit Shubham R., Pande Vishal V., Giri Mahendra A


The expression "biobetter" was probably designed by Mr. G.V. Prasad, CEO of Dr. Reddy's Laboratories, at a Bioinvestor's gathering in Mumbai, India, in 2007 and has been too much utilized from that point onward, potentially to a certain extent, where there is no brought together definition for this advertising term. [2]. Biobetters or biosuperiors are new biologic substances that are enhanced variants of a unique biologic. The separation from the first biologic might be as enhanced viability/strength’s security, immunogenicity or an adjustment in the course of conveyance or dosing recurrence or upgrades in assembling forms. Certain biobetters may discover use in various or more extensive patient gatherings. Their amino corrosive successions nearly take after the first biologic, yet are marginally altered. In the course of recent years expansive number of more up to date definition procedures and new biologics were produced, and each framework has a few points of interest and disservices over the others. Other than that; Biobetter is one of the one of a kind method for more current biologics with presumptions of Targeting and Controlling of Drugs in the people; in light of manual change with auxiliary part which help in holding the medication molecule in best design that hold like a pocket and give complete conjugation.


Keywords: Biobetters, Biosimilars, Biosuperior, Development, Monoclonal Antibody


Cite this Article

Pandit Shubham R, Pande Vishal V. , Giri Mahendra A. Biobetter Formulations: Innovative Milestone for Original Biologics. Research & Reviews: A Journal of Drug Formulation, Development and Production. 2020; 7(2): 62–71p.

Full Text:



  • There are currently no refbacks.

Copyright (c) 2020 Research & Reviews: A Journal of Drug Formulation, Development and Production